Methyl 1-(2-methoxy-2-oxoethyl)-1h-pyrazole-4-carboxylate, 97%, 100mg

(2-phenylpyridin-3-yl)methanamine dihydrochloride, 95.0%, 500mg

2-Methyl-2,7-diazaspiro[4.5]decan-3-one hydrochloride, 98%, 250mg

(S)-3-Methyl-piperidine hydrochloride, 98.0%, 1g

Flacons à fond rond à trois cols cols latéraux parallèles, 2000 ml, 29/32, 29/32, 1 pièce

(R)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid, 95.0%, 1g

N-alpha-Boc-N-gamma-Fmoc-L-Diaminobutyric acid, 98.0%, 10g

4-(4,4-Difluoro-1-piperidyl)aniline, 98%, 250mg

6-CHLOROTHIAZOLO[4,5-B]PYRIDIN-2-AMINE, 97.0%, 1g

iso-Propyl trifluoroacetate, 98.0%, 1g

tert-butyl 4-(2-aminoethyl)-1-piperazinecarboxylate hydrochloride trihydrate, 95.0%, 1g

5-(Trifluoromethyl)pyridin-2-ylamidoxime, 95.0%, 1g

3-BROMO-2-METHYL-N-(3-(METHYLSULFONYL)BENZYL)IMIDAZO[1,2-A]PYRAZIN-8-AMINE, 90.0%, 500mg